By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Markets > Stocks > J&J’s Kenvue valued at $48 billion after shares jump in market debut
Stocks

J&J’s Kenvue valued at $48 billion after shares jump in market debut

News Room
Last updated: 2023/05/07 at 4:59 AM
By News Room
Share
3 Min Read
SHARE

© Reuters. The company logo for Johnson & Johnson is displayed to celebrate the 75th anniversary of the company’s listing at the New York Stock Exchange (NYSE) in New York, U.S., September 17, 2019. REUTERS/Brendan McDermid

(Reuters) -Johnson & Johnson’s consumer health spinoff Kenvue Inc rose 16% and fetched a valuation of about $48 billion in its market debut on Thursday, marking the biggest U.S. initial public offering since 2021.

Shares of the Listerine mouthwash maker debuted at $25.53 each, compared with their offer price of $22 apiece.

J&J (NYSE:) sold 172.8 million shares of the business in an upsized offering to raise $3.8 billion, and said it will continue to own a stake of about 91% in Kenvue.

Kenvue’s stellar debut comes as good news for hopefuls waiting for market conditions to improve before moving ahead with their listings, in an IPO market that has largely been frozen over the past year due to stock-market volatility and economic uncertainty.

“Investors are very valuation sensitive now, and Kenvue is easier to pin a value on than, say, a tech unicorn. It has mature brands … consumers should continue to buy these brands even in a recession,” Matt Kennedy, senior strategist at Renaissance Capital, said.

Kenvue marks the largest offering to launch since electric-vehicle maker Rivian Automotive Inc listed its shares on the Nasdaq in late 2021.

IPOs in the U.S., excluding SPACs, raised a record $154.07 billion in 2021, which fell to $8.63 billion last year as markets reeled under macroeconomic uncertainty, data from Dealogic showed.

U.S. IPOs, excluding listings for SPACs, are down about 22% to a total of just $2.35 billion from the start of 2023 till May 3.

J&J shares fell marginally to $162 after Kenvue, whose products have long been the face of the company, debuted.

Kenvue’s listing comes a year after J&J’s British rival GSK also completed the spinoff of its consumer health business. Shares of the London-listed arm called Haleon have risen 9.4% from their closing price on debut day in July 2022.

Read the full article here

News Room May 7, 2023 May 7, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
NeuroOne Medical Technologies Corporation 2025 Q1 – Results – Earnings Call Presentation (NASDAQ:NMTC)

This article was written byFollowSeeking Alpha's transcripts team is responsible for the…

UnitedHealth chief Andrew Witty steps down after share plunge

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

US inflation falls to 2.3% in April

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

Donald Trump’s gargantuan self-dealing

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

EU readies capital controls and tariffs to safeguard Russia sanctions

Stay informed with free updatesSimply sign up to the War in Ukraine…

- Advertisement -
Ad imageAd image

You Might Also Like

Stocks

CPS reports solid 2023 performance, eyes future growth By Investing.com

By News Room
Stocks

Niu Technologies faces mixed results in Q4 2023 By Investing.com

By News Room
Stocks

Exagen Inc. reports strong 2023 revenue growth By Investing.com

By News Room
Stocks

Legacy Housing reports mixed results amid sales decline By Investing.com

By News Room
Stocks

Harmony Biosciences exec sells over $383k in stock By Investing.com

By News Room
Stocks

Biofrontera posts record revenue and outlines growth plans By Investing.com

By News Room
Stocks

Granite Ridge CFO buys $31,000 in company stock By Investing.com

By News Room
Stocks

Coliseum Capital Management buys MasterCraft Boat shares worth over $3.2m By Investing.com

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?